WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)
Malaria infection during pregnancy is a major public health problem, with substantial risks for the mother, her fetus and the newborn. In areas with moderate to high transmission of Plasmodium falciparum, the World Health Organization (WHO) recommends a package of interventions for controlling malaria and its effects during pregnancy, which includes the promotion and use of insecticide-treated nets (ITNs), the administration during pregnancy of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), and appropriate case management through prompt and effective treatment of malaria in pregnant women.
Assurance Qualité, Politique, Renforcement des capacités, Usage
- Sous-catégories Paludisme
- Commodities Médicaments, Moustiquaires, Vaccins
- Date de mise à jour April 2013
- Version
- Développé par WHO/OMS
- Quand l'utiliser Malaria infection during pregnancy is a major public health problem, with substantial risks for the mother, her fetus and the newborn. In areas with moderate to high transmission of Plasmodium falciparum, the World Health Organization (WHO) recommends a package of interventions for controlling malaria and its effects during pregnancy, which includes the promotion and use of insecticide-treated nets (ITNs), the administration during pregnancy of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), and appropriate case management through prompt and effective treatment of malaria in pregnant women.
- Langues Anglais
- Niveau d'utilisation Central, Régional
- Forme pdf document
- Amount of training / TA required n/a
- Inputs & outputs n/a
- Coût free
- Advantages n/a
- Contraintes n/a
- Disponibilité http://www.who.int/entity/malaria/publications/atoz/Policy_brief_IPTp-SP_implementation_11april2013.pdf.pdf
- Remarques
- Contact Silvia Schwarte, WHO (schwartes@who.int)
- Submission date 2013-05-21 18:44:13